Pfizer Inc (NYSE:PFE) is moving into the gene therapy space in the latest sign that the technology for fixing faulty genes may finally be ready for prime time, following earlier setbacks. Pfizer Inc. (NYSE:PFE) belongs to Healthcare sector. Its net profit margin is 64.40% and weekly performance is 2.27%. On last trading day company shares ended up $31.97. Pfizer Inc. (NYSE:PFE) distance from 50-day simple … Continue reading Stocks Gaining Momentum: Pfizer Inc. (NYSE:PFE), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Stoneridge Inc. (NYSE:SRI), Total System Services, Inc. (NYSE:TSS), Comcast Corporation (NASDAQ:CMCSA)